September 9, 2009: NanoInk is introducing a contract research program to provide miniaturization and multiplex protein analysis.
The program, part of the company’s "Nano BioDiscovery" division, is based on its patented dip-pen nanolithography platform and its experience in array fabrication. Features of the offering range from complete custom assay development and analysis projects to protein profiling work, to custom array printing. Researchers "develop the custom assay protocol, fabricate the custom nanoarrays, conduct on-array assays, extract and analyze data, and develop a comprehensive final report that includes image files and raw data," explain Bruce Dudzik, senior director for business development, in a statement.
The dip-pen litho technology can deposit highly reproducible submicron protein features in a subarray and pattern up to 96 subarrays per slide. Nanoscale protein arrays enable multi-parallel, high throughput analysis. "By combing DPN nanofabrication technology with optimized substrates and next-generation detection systems for a total system solution, Nano BioDiscovery helps its customers address major proteomic challenge," the company states.